ULTRASE (Ultrase amylase 20,000 units; lipase 4500 units; protease 25,000 units)
Generic Name: pancrelipase
Pill imprint ULTRASE has been identified as Ultrase amylase 20,000 units; lipase 4500 units; protease 25,000 units.
Ultrase is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Ultrase amylase 20,000 units; lipase 4500 units; protease 25,000 units is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- amylase 20,000 units; lipase 4500 units; protease 25,000 units
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Axcan Scandipharm Inc.
More about Ultrase (pancrelipase)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: digestive enzymes
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.